41
Executive Compensation: Insights from the 2013 CompStudy Survey LIFE SCIENCES & HEALTHCARE EDITION Life Sciences Edition

Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

Embed Size (px)

DESCRIPTION

Executive Compensation: Insights from the 2013 CompStudy Survey, Life Sciences & Healthcare Edition Explores the CompStudy as well as: - Current Founder’s Dilemmas research - 2013 survey – company profiles - Summary compensation data - CEO compensation review - Hot topics and current trends

Citation preview

Page 1: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

Executive Compensation: Insights from the 2013 CompStudy Survey

LIFE SCIENCES & HEALTHCARE EDITION

Life Sciences Edition

Page 2: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

www.compstudy.com | 2

Today’s moderator

Bryan Pearce Partner, Americas Director, EY

Entrepreneur of the Year, EY

Presented by Park Square, WilmerHale and EY

Page 3: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

www.compstudy.com | 3

Today’s presenters

Erik R. Lundh Park Square Managing Partner

Rosemary Reilly WilmerHale Partner

Kimberly Wethly WilmerHale Partner

Bruce Booth Atlas Ventures Partner

Presented by Park Square, WilmerHale and EY

Glen Giovannetti EY Global Life Sciences Sector Leader

Noam Wasserman Harvard Business School Associate Professor, Tukman Faculty Fellow

Page 4: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

www.compstudy.com | 4

Today’s agenda

• CompStudy overview

• Current Founder’s Dilemmas research

• 2013 survey – company profiles

• Summary compensation data

• CEO compensation review

• Hot topics and current trends

Presented by Park Square, WilmerHale and EY

Page 5: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

www.compstudy.com | 5

CompStudy Overview

Presented by Park Square, WilmerHale and EY

CompStudy.com • All reporting now done on our online, fully interactive

platform, located at CompStudy.com.

• Participants in the annual survey receive free, year-long access to the reports. Access is also available for purchase.

• New features for 2013:

New options for filtering the data, including company valuation, profitability, CEO experience, and more

Enhanced Board of Directors reporting

Additional printable summary- level charts

Page 6: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

www.compstudy.com | 6

The CompStudy.com Survey Data collected in every survey includes:

• Cash compensation and equity

• Founding team

• Financing history

• Company size

• Products/revenue

• Equity programs

• Executive backgrounds

• Board of directors

CompStudy Overview

Presented by Park Square, WilmerHale and EY

Life Sciences Survey

2002 2013

168 cos. 256 cos.

Technology Survey

2000 2013

211 cos. 550 cos.

Page 7: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

www.compstudy.com | 7

Today’s agenda

• CompStudy overview

• Current Founder’s Dilemmas research

• 2013 survey – company profiles

• Summary compensation data

• CEO compensation review

• Hot topics and current trends

Presented by Park Square, WilmerHale and EY

Page 8: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights
Page 9: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

Founding

When to Found

Building the Team

Beyond the Team

Exit Dilemmas

New-Venture Hiring

CORE DILEMMAS

Y

Y

Y

Y

Y

CORE FOUNDER

CO-FOUNDERS

INVESTORS, PARTNERS

ALL OF THE ABOVE

HIRES

Page 10: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

16,000 founders

THE RESEARCH

6,300 startups

31,000 executives

Page 11: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

Kaplan-Meier survival estimate95%, pointwise confidence band shown

l i ti0 50 100

0.00

0.25

0.50

0.75

1.00

.

111223318

7916525335 14 23

6323 4 4

45

3

2

# of months

Page 12: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

http://techcrunch.com/2011/03/03/jack-dorsey-twitter-punched-stomach/

It was like being punched in the stomach. ” “

Page 13: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

“RICH VS. KING”

RICH

KING

Flop

Rich & King

Small Player

Big Player

Low High FINANCIAL GAINS

CON

TRO

L

Page 14: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

Value

Control

N=3,775 IT and LS startups, 2005-2012

Page 15: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

6% 15% 17%

14% 15% 15%

12% 4% 3%

Value

Control

N=3,775 IT and LS startups, 2005-2012

Page 16: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

For my part, I had rather be the first man among these [lesser] fellows, than the second man in Rome. ”

Page 17: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

05

101520253035

POST-SUCCESSION EXECUTIVE ROLES

05

101520253035

Source: Wasserman (2008), “Replacing the Founder,” 212 ventures .

Page 18: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

• Detailed table of contents • Chapter 1 • Self-assessment survey • “When to Leap” video • Other awesome stuff

NoamWasserman.com

Page 19: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

www.compstudy.com | 19

Audience Poll

Presented by Park Square, WilmerHale and EY

What is your company’s outlook on the economy over the next 12-18 months:

A. Things are good and getting better

B. Still receiving mixed signals from the market

C. Growing increasingly concerned about a downturn

Webinar poll results: A. 44% B. 47% C. 9%

Page 20: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

www.compstudy.com | 20

Today’s agenda

• CompStudy overview

• Current Founder’s Dilemmas research

• 2013 survey – company profiles

• Summary compensation data

• CEO compensation review

• Hot topics and current trends

Presented by Park Square, WilmerHale and EY

Page 21: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

www.compstudy.com | 21

2013 Survey – Company Profiles

Number of full time employees

Headcount Institutional rounds raised

Number of rounds

Later stage companies are better-represented in this year’s survey; 82% of the companies surveyed have raised 2+ rounds of financing, compared to 78% in 2012.

% respondents in this range % respondents in this range

Respondent company headcounts were slightly larger than in 2012, though the distribution is fairly close.

Presented by Park Square, WilmerHale and EY

Page 22: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

www.compstudy.com | 22

2013 Survey – Company Profiles

Business Segments

Geography % respondents in this range

% respondents in this range

Revenue

Presented by Park Square, WilmerHale and EY

Page 23: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

www.compstudy.com | 23

2013 Survey – Company Profiles Founder status - % of role held by founders vs. non-founders Participants had essentially the same founder/non-founder split by position profile as in 2012

Presented by Park Square, WilmerHale and EY

Page 24: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

www.compstudy.com | 24

Audience Poll

What change do you anticipate for base salaries next year?

A. Decrease

B. No change

C. Increase up to 5%

D. Increase between 5% and 10%

E. Increase more than 10%

Webinar poll results: A. 1% B. 17% C. 70% D. 9% E. 3%

Presented by Park Square, WilmerHale and EY

Page 25: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

www.compstudy.com | 25

Today’s agenda

• CompStudy overview

• Current Founder’s Dilemmas research

• 2013 survey – company profiles

• Summary compensation data

• CEO compensation review

• Hot topics and current trends

Presented by Park Square, WilmerHale and EY

Page 26: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

www.compstudy.com | 26

Compensation data Founder cash compensation

Founder CEO salaries were up slightly less than their non-founder peers: 0.9% vs 1.42%

Presented by Park Square, WilmerHale and EY

*Fewer positions shown due to lack of founders in certain roles

Page 27: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

www.compstudy.com | 27

Compensation data

Founder current equity holdings, as % of fully diluted shares

On the average, founders of life sciences companies hold significantly less equity than their technology peers – largely due to the more capital-intensive nature of most life sciences start-ups.

Presented by Park Square, WilmerHale and EY

% equity owned, fully diluted

*Fewer positions shown due to lack of founders in certain roles

Page 28: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

www.compstudy.com | 28

CompStudy Overview Percentage growth in year-over-year non-founder total target cash compensation

Presented by Park Square, WilmerHale and EY

Page 29: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

www.compstudy.com | 29

Compensation data Cash compensation – non-founders, 2012 and 2013 Non-founder total target cash compensation was up 3% in 2013, down slightly from the 3.5% rate of increase between 2011 and 2012.

Presented by Park Square, WilmerHale and EY

Page 30: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

www.compstudy.com | 30

Compensation data Bonus as a percentage of base salaries – non-founders On average in 2012, non-founder executives received 67.8% of their target bonuses, up slightly from 65.5% in 2011.

Presented by Park Square, WilmerHale and EY

% of base salary

Page 31: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

www.compstudy.com | 31

Compensation data

Current equity - % of fully diluted shares

Equity at hire - % of fully diluted shares

Equity holdings – non-founder executives

Presented by Park Square, WilmerHale and EY

Page 32: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

www.compstudy.com | 32

Audience Poll

What percentage of the equity in your company is reserved for management, directors and employees?

A. Less than 10%

B. 11 – 15%

C. 16 – 20%

D. 21 – 25%

E. More than 25%

Webinar poll results: A. 29% B. 36% C. 20% D. 5% E. 9%

Presented by Park Square, WilmerHale and EY

Page 33: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

www.compstudy.com | 33

Compensation data

Equity holdings – type of equity vehicles used % of equity grants given by vehicle type

Presented by Park Square, WilmerHale and EY

Page 34: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

www.compstudy.com | 34

Compensation data Percentage of non-founder executives eligible for severance 67.3% of non-founder CEOs surveyed had some sort of severance package, down from the survey’s historical average of 73%. No other position exceeded 50% participation.

Presented by Park Square, WilmerHale and EY

% eligible for severance

Page 35: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

www.compstudy.com | 35

Compensation data Length of severance packages granted (months) As the median numbers suggest, the length of nearly every severance package granted is a multiple of three months

Presented by Park Square, WilmerHale and EY

Page 36: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

www.compstudy.com | 36

Today’s agenda

• CompStudy overview

• Current Founder’s Dilemmas research

• 2013 survey – company profiles

• Summary compensation data

• CEO compensation review

• Hot topics and current trends

Presented by Park Square, WilmerHale and EY

Page 37: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

www.compstudy.com | 37

CEO compensation review

By number of financing rounds raised By number of full time employees

Non-founder CEO base (1,000s USD) CEO salaries are more highly correlated with company headcount, as evidenced in the chart above by the large gap in pay between CEOs at 1-20 FTE companies and CEOs at 21-40 FTE companies

Presented by Park Square, WilmerHale and EY

Page 38: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

www.compstudy.com | 38

CEO compensation review Non-founder CEO current equity (% of fully diluted shares) Headcount is a slightly better predictor of non-founder CEO equity; there is a lot of variability in the data when sliced by financing status. This is partly attributable to difference between therapeutics companies and all others in the survey; more filters can be applied at CompStudy.com

By number of financing rounds raised By number of full time employees

Presented by Park Square, WilmerHale and EY

Page 39: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

www.compstudy.com | 39

Today’s agenda

• CompStudy overview

• Current Founder’s Dilemmas research

• 2013 survey – company profiles

• Summary compensation data

• CEO compensation review

• Hot topics and current trends

Presented by Park Square, WilmerHale and EY

Page 40: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

www.compstudy.com | 40

Hot topics and current

trends

• Recruiting and retaining top talent in an increasingly competitive market - Founder transitions - Recruiting dynamics - Retention issues

• Compensation differences between earlier and later stage companies

• Alternatives to dilutive equity issuances

• 409A Valuations

• Compensation in a holding company model

Presented by Park Square, WilmerHale and EY

Page 41: Executive Compensation: Life Sciences & HealthCare 2013 CompStudy Insights

www.compstudy.com | 41

Recap • 1-minute recap from each panelist

Presented by Park Square, WilmerHale and EY